EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

T helper 2 cell–directed immunotherapy eliminates precancerous skin lesions

Tomonori Oka, Sabrina S Smith, Heehwa G Son, Truelian Lee, Valeria S Oliver-Garcia, Mahsa Mortaja, Kathryn E Trerice, Lily S Isakoff, Danielle N Conrad, Marjan Azin, Neel S Raval, Mary Tabacchi und 5 weitere

Journal of Clinical Investigation · 02.01.2025 · 135 (1)

DOI: 10.1172/jci183274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 02.01.2025. Verfasst von Tomonori Oka und 16 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cancer Immunology and Cutaneous Biology Research Center, Krantz Family Center for Cancer Research and Department of Dermatology, Massachus…. Hauptthemen laut MEDLINE: Skin Neoplasms, Th2 Cells, Precancerous Conditions, Calcitriol. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIAMS NIH HHS, Burroughs Wellcome Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The continuous rise in skin cancer incidence highlights an imperative for improved skin cancer prevention. Topical calcipotriol-plus–5-fluorouracil (calcipotriol-plus–5-FU) immunotherapy effectively eliminates precancerous skin lesions and prevents squamous cell carcinoma (SCC) in patients. However, its mechanism of action remains unclear. Herein, we demonstrate that calcipotriol-plus–5-FU immunotherapy induces T helper type 2 (Th2) immunity, eliminating premalignant keratinocytes in humans. CD4 + Th2 cells were required and were sufficient downstream of thymic stromal lymphopoietin cytokine induction by calcipotriol to suppress skin cancer development. Th2-associated cytokines induced IL-24 expression in cancer cells, resulting in toxic autophagy and anoikis followed by apoptosis. Calcipotriol-plus–5-FU immunotherapy was dependent on IL-24 to suppress skin carcinogenesis in vivo. Collectively, our findings establish a critical role for Th2 immunity in cancer immunoprevention and highlight the Th2/IL-24 axis as an innovative target for skin cancer prevention and therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsTh2 CellsPrecancerous ConditionsCalcitriolInterleukinsFluorouracilHumansAnimalsMiceImmunotherapyKeratinocytesCarcinoma, Squamous CellCytokinesInterleukin-24

Stichwörter der Autor:innen

DermatologyImmunotherapyOncologySkin cancerT cells

Substanzen

CalcitriolInterleukinsFluorouracilCytokinesInterleukin-24calcipotriene

Autor:innen und Institutionen

  • Center for Cancer Immunology and Cutaneous Biology Research Center, Krantz Family Center for Cancer Research and Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Division of Dermatology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Department of Human and Molecular Genetics, Virginia Commonwealth University, School of Medicine, Richmond, Virginia, USA.
  • VCU Institute of Molecular Medicine, Virginia Commonwealth University, School of Medicine, Richmond, Virginia, USA.
  • VCU Massey Comprehensive Cancer Center, Virginia Commonwealth University, School of Medicine, Richmond, Virginia, USA.
  • Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Förderung

  • NCI NIH HHS
  • NIAMS NIH HHS
  • Burroughs Wellcome Fund
  • LEO Fondet
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • National Cancer Institute

Zitieren

APA

Oka, T., Smith, S. S., Son, H. G., Lee, T., Oliver-Garcia, V. S., Mortaja, M., Trerice, K. E., Isakoff, L. S., Conrad, D. N., Azin, M., Raval, N. S., Tabacchi, M., Emdad, L., Das, S. K., Fisher, P. B., Cornelius, L. A., & Demehri, S. (2025). T helper 2 cell–directed immunotherapy eliminates precancerous skin lesions. Journal of Clinical Investigation, 135(1). https://doi.org/10.1172/jci183274

Vancouver

Oka T, Smith SS, Son HG, Lee T, Oliver-Garcia VS, Mortaja M, et al. T helper 2 cell–directed immunotherapy eliminates precancerous skin lesions. Journal of Clinical Investigation. 2025;135(1). doi:10.1172/jci183274

BibTeX
@article{Oka2025,
  author = {Oka, Tomonori and Smith, Sabrina S and Son, Heehwa G and Lee, Truelian and Oliver-Garcia, Valeria S and Mortaja, Mahsa and Trerice, Kathryn E and Isakoff, Lily S and Conrad, Danielle N and Azin, Marjan and Raval, Neel S and Tabacchi, Mary and Emdad, Luni and Das, Swadesh K and Fisher, Paul B and Cornelius, Lynn A and Demehri, Shadmehr},
  title = {T helper 2 cell–directed immunotherapy eliminates precancerous skin lesions},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  volume = {135},
  number = {1},
  doi = {10.1172/jci183274}
}
Kostenlos starten →